Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : nhmcf -- Ignore unavailable to you. Want to Upgrade?

To: SnakeInATuxedo who wrote (586)	6/29/1998 9:08:00 AM
From: Milk	Read Replies (1) \| Respond to of 702

*Paradigm Medical Industries and National Healthcare Form Ophthalmic Product Alliance with Pharmacia & Upjohn* Monday June 29, 7:30 am Eastern Time Company Press Release SOURCE: Paradigm Medical Industries, Inc. Paradigm Medical Industries and National Healthcare Form Ophthalmic Product Alliance with Pharmacia & Upjohn SALT LAKE CITY, June 29 /PRNewswire/ -- Paradigm Medical Industries, Inc. (Nasdaq: PMED - news) and National Healthcare Manufacturing Corporation (Nasdaq: NHMCF - news) announced today that they have signed a co-distribution agreement with Pharmacia & Upjohn (NYSE: PNU - news) covering a range of ophthalmic products. Under terms of the agreement, the three companies will offer a comprehensive package of products to cataract surgeons, including cataract surgical equipment, intraocular lens implants, intraocular pharmaceuticals, surgical instruments, and sterile procedure packs. Paradigm will provide a turnkey ordering and delivery of products from its Salt Lake City headquarters; National Healthcare will employ its fully automated production facility to package a line of standard and custom sterile cataract procedural packs. Pharmacia & Upjohn products to be distributed as part of the alliance agreement include Healon(R) and Healon GV(R) viscoelastic solution and the CeeOn line of foldable, small-incision intraocular lens implants, designed to replace the natural lens removed during cataract surgery. ''The combined products and services covered by this agreement are in response to the need for improved, flexible customer support in the cataract surgery field,'' said Michael Stelzer, Paradigm Chief Operating Officer and Paradigm Pharmacia & Upjohn Alliance program coordinator. ''This alliance with National Healthcare and Pharmacia & Upjohn will provide a comprehensive, customer-focused product line to the 17,000 cataract surgeons in the United States.'' Paradigm is a high technology ophthalmic device company that manufactures the Precisionist ThirtyThousand(TM) ophthalmic workstation, utilized in cataract surgery for phacoemulsification. Paradigm is currently conducting clinical trials in the United States for its Photon(TM) laser cataract removal system. National Healthcare's commitment to reducing healthcare costs has led to widespread recognition as a market leader. This cost reduction is realized by offering healthcare providers efficient and cost effective alternatives to conventional products and services. National Healthcare owns and operates the world's first and only automated robotic production facility capable of assembling and packaging various kits and trays for medical and surgical procedures. Through its wholly owned subsidiaries, National Healthcare manufactures and distributes personal care, anti-microbial, cellulose-based paper products-such as examination gowns-to healthcare and homecare institutions throughout North America and Europe. In addition, National Healthcare Logistics (a National Healthcare subsidiary) is redefining conventional medical distribution with its state-of-the-art Hub & Spokes logistics system. SOURCE: Paradigm Medical Industries, Inc.